Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Xeris Biopharma Holdings Inc. buy Craig Hallum

Xeris Biopharma Holdings Inc.
Start price
€2.12
28.08.23 / 50%
Target price
€4.16
28.08.24
Performance (%)
20.38%
End price
€2.55
29.08.24
Summary
This prediction ended on 29.08.24 with a price of €2.55. The prediction had a final performance of 20.38%. Craig_Hallum has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Xeris Biopharma Holdings Inc. 2.477% 2.477% 13.940%
iShares Core DAX® -1,28 % 4,21 % 7,08 %
iShares Nasdaq 100 -3,34 % -1,74 % 26,18 %
iShares Nikkei 225® -4,29 % -1,62 % 44,32 %
iShares S&P 500 -2,31 % -0,10 % 20,82 %

Comments by Craig_Hallum for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 20.38%
Target price 4.161
Change
Ends at 28.08.24

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $4.50 price target on the stock.
Ratings data for XERS provided by MarketBeat

Craig Hallum 
0
Report Share
28.08.23
In the thread Trading Xeris Biopharma Holdings Inc.
Prediction Buy
Perf. (%) 20.38%
Target price 4.161
Change
Ends at 28.08.24

Die von Craig_Hallum gewählte maximale Laufzeit wurde überschritten

Craig Hallum 
0
Report Share
29.08.24

Stopped prediction by Craig_Hallum for Xeris Biopharma Holdings Inc.

buy
Xeris Biopharma Holdings Inc.

Start price
Target price
Perf. (%)
€4.21
10.03.25
€5.98
10.03.26
17.02%
11.03.26

Craig Hallum 
10.03.25 50%